Maxvert 16mg Tablet contains Betahistine dihydrochloride, an active pharmaceutical ingredient commonly prescribed for the management of vertigo and Ménière’s disease. Betahistine acts as a histamine analogue, primarily exerting its therapeutic effect by improving microcirculation in the inner ear, thereby reducing vestibular symptoms such as dizziness, tinnitus, and hearing loss. The 16mg dosage is designed to provide effective symptom control while minimizing adverse effects. Maxvert is indicated for patients experiencing recurrent episodes of vertigo associated with vestibular disorders, including Ménière’s disease, where it helps to alleviate the sensation of spinning and imbalance. The mechanism involves vasodilation of the blood vessels in the inner ear, enhancing blood flow and reducing endolymphatic pressure. Maxvert 16mg Tablet is typically administered orally, with dosage and duration tailored according to clinical response and patient tolerance. Common side effects may include gastrointestinal discomfort, headache, or allergic reactions, though these are generally mild and transient. Contraindications include pheochromocytoma and hypersensitivity to Betahistine or any excipients. Caution is advised in patients with asthma or peptic ulcer disease. Overall, Maxvert 16mg offers a targeted approach to managing vestibular dysfunction, improving patient quality of life through symptom relief.